Pesquisas alternativas:
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
1
Por Arroyo-Currás, Netzahualcóyotl, Ortega, Gabriel, Copp, David A., Ploense, Kyle L., Plaxco, Zoe A., Kippin, Tod E., Hespanha, João P., Plaxco, Kevin W.
Publicado no ACS Pharmacol Transl Sci (2018)
“..., the ability to perform feedback-controlled dosing informed by high-frequency in vivo drug measurements would...”Publicado no ACS Pharmacol Transl Sci (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Treijtel, Nicoline, Collins, Christiane, van Bruijnsvoort, Michel, Fuhr, Rainard, Ernault, Etienne, Gangaram‐Panday, Shanti, Passier, Paul
Publicado no Clin Pharmacol Drug Dev (2019)
“..., the inhibiting effect of a perpetrator drug on different CYP enzymes can be evaluated, and at different doses...”Publicado no Clin Pharmacol Drug Dev (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Heard, Kennon, Green, Jody L., Anderson, Victoria, Bucher‐Bartelson, Becki, Dart, Richard C.
Publicado no Br J Clin Pharmacol (2016)
Assuntos:
“...Drug Metabolisms...”Publicado no Br J Clin Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Veal, Gareth J., Errington, Julie, Sastry, Jairam, Chisholm, Julia, Brock, Penelope, Morgenstern, Daniel, Pritchard-Jones, Kathy, Chowdhury, Tanzina
Publicado no Cancer Chemother Pharmacol (2016)
“... to the clinical pharmacology of anticancer drugs in these challenging patients, current dosing guidelines...”Publicado no Cancer Chemother Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
“.... METHODS: We describe a new dose-finding design which can be used for multiple-drug trials and can...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... studied the relationship between plasma level of PB and dose (2-16 mg daily) following 3 or 4 weeks...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
“...Although blood is the basic test material to monitor levels of antipsychotic drugs in a person’s...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Tomita, Takashi, Goto, Hidekazu, Yoshida, Tadashi, Tanaka, Katsuya, Sumiya, Kenji, Kohda, Yukinao
Publicado no Indian J Pharmacol (2015)
Assuntos:
“...Drug Watch...”Publicado no Indian J Pharmacol (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Darpo, Borje, Xue, Hongqi, Adetoro, Nikki, Matthews, Barbara G., Pentikis, Helen S.
Publicado no J Clin Pharmacol (2017)
Assuntos:
“...Drug Development...”Publicado no J Clin Pharmacol (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Kloiber, Stefan, Ripke, Stephan, Kohli, Martin A., Reppermund, Simone, Salyakina, Daria, Uher, Rudolf, McGuffin, Peter, Perlis, Roy H., Hamilton, Steven P., Pütz, Benno, Hennings, Johannes, Brückl, Tanja, Klengel, Torsten, Bettecken, Thomas, Ising, Marcus, Uhr, Manfred, Dose, Tatjana, Unschuld, Paul G., Zihl, Josef, Binder, Elisabeth, Müller-Myhsok, Bertram, Holsboer, Florian, Lucae, Susanne
Publicado no Eur Neuropsychopharmacol (2012)
“...-analysis combining results from the MARS study with data from the Genome-based Therapeutic Drugs...”Publicado no Eur Neuropsychopharmacol (2012)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“... and was related to serum and cerebrospinal fluid drug levels. Repeated 2-week treatment with risperidone...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Hendrikx, Jeroen J.M.A., Haanen, John B.A.G., Voest, Emile E., Schellens, Jan H.M., Huitema, Alwin D.R., Beijnen, Jos H.
Publicado no Oncologist (2017)
Assuntos:
“...New Drug Development and Clinical Pharmacology...”Publicado no Oncologist (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Euteneuer, Joshua C., Kamatkar, Suyog, Fukuda, Tsuyoshi, Vinks, Alexander A., Akinbi, Henry T.
Publicado no J Clin Pharmacol (2018)
“... with scaling by bodyweight or body surface area. This may lead to drug dosing that is unsafe or ineffective...”Publicado no J Clin Pharmacol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Stringer, Jeffrey S. A., Sinkala, Moses, Chapman, Victoria, Acosta, Edward P., Aldrovandi, Grace M., Mudenda, Victor, Stout, Julia P., Goldenberg, Robert L., Kumwenda, Rosemary, Vermund, Sten H.
Publicado em 2003
“... a ‘sub-therapeutic’ NVP level of less than 100 ng/ml (56 versus 20%; P < 0.001) than those who...”Publicado em 2003
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... of salbutamol pressurized metered-dose inhalers (pMDIs), as well as salbutamol Diskus, leading to a decline...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Ballantyne, Christie M, Laufs, Ulrich, Ray, Kausik K, Leiter, Lawrence A, Bays, Harold E, Goldberg, Anne C, Stroes, Erik SG, MacDougall, Diane, Zhao, Xin, Catapano, Alberico L
Publicado no Eur J Prev Cardiol (2019)
Assuntos:
“...Drug Treatment...”Publicado no Eur J Prev Cardiol (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
“..., but the available results indicate higher efficacy at higher dose levels. None of the known side effects...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Tyson, Rachel J., Park, Christine C., Powell, J. Robert, Patterson, J. Herbert, Weiner, Daniel, Watkins, Paul B., Gonzalez, Daniel
Publicado no Front Pharmacol (2020)
“...The administered dose of a drug modulates whether patients will experience optimal effectiveness...”Publicado no Front Pharmacol (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... in those who had not completed a one-year INF therapy cycle). According to the total dose of INF...”
Obter o texto integral
Obter o texto integral
Artigo
20
Por Lee Sue J, Stepniewska Kasia, Aguas Ricardo, Saralamba Sompob, Maude Richard J, Pongtavornpinyo Wirichada, White Nicholas J, Dondorp Arjen M, White Lisa J, Day Nicholas PJ
Publicado em 2009-11-01
“... inadequate treatments. Resistance to artemisinins is, therefore, unlikely to emerge with single drug...”Publicado em 2009-11-01
Obter o texto integral
Artigo